Chronic respiratory care for neuromuscular diseases in adults

European Respiratory Journal

Volumn 34, Issue 2, 2008, Pages 444-451

  Ambrosino, N ^a,b   Carpene N ^a   Gherardi, M ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b Pulmonary Rehabilitation and Long Term Weaning Unit   (Italy)

Author keywords

Chronic respiratory insufficiency; Chronic ventilatory support; Cough capacity; Health related quality of life; Home ventilation; Inspiratory muscles

Indexed keywords

AERATION; AMYOTROPHIC LATERAL SCLEROSIS; ARTIFICIAL VENTILATION; BREATHING; BULBAR PARALYSIS; COUGHING; GAS EXCHANGE; GLOSSOPHARYNGEAL BREATHING; HUMAN; HYPOVENTILATION; LONG TERM CARE; LUNG CLEARANCE; LUNG INFLATION; MANUALLY ASSISTED COUGHING; MECHANICALLY ASSISTED COUGHING; MUSCULAR DYSTROPHY; NEUROMUSCULAR DISEASE; NON INVASIVE MECHANICAL VENTILATION; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY FAILURE; REVIEW; SURVIVAL RATE; TECHNIQUE; TRACHEOSTOMY; TREATMENT OUTCOME;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; COUGH; HUMANS; INSUFFLATION; MUSCULAR DYSTROPHIES; NEUROMUSCULAR DISEASES; PULMONARY MEDICINE; QUALITY OF LIFE; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; RESPIRATORY SYSTEM; RESPIRATORY THERAPY; TRACHEOSTOMY;

EID: 69249154296     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00182208     Document Type: Review

References (84)

1. Perrin C, Unterborn JN, Ambrosio CD, et al. Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve 2004; 29: 5-27.
2. Hill M, Hughes T, Milford C. Treatment for swallowing difficulties (dysphagia) in chronic muscle disease. Cochrane Database Syst Rev 2004; 2: CD004303.
3. Newson-Davies J. The Lambert-Eaton myasthenic syndrome. In: Engel AG, ed. Myology. 3rd Edn. New York, McGraw Hill, 2004; p. 1800.
4. Gozal D. Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy. Pediatr Pulmonol 2000; 29: 141-150.
5. Bach JR. Progressive neuromuscular and degenerative diseases. In: Ambrosino N, Goldstein RS, eds. Ventilatory Support for Chronic Respiratory Failure. New York, Informa Healthcare Pub, 2008; pp. 445-455.
6. Vitacca M, Clini E, Facchetti D, et al. Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis. Eur Respir J 1997; 10: 1614-1621.
7. Polkey MI, Lyall RA, Moxham J, et al. Respiratory aspects of neurological disease. J Neurol Neurosurg Psychiatry 1999; 66: 5-15.
8. Polkey MI, Lyall RA, Green M, et al. Expiratory muscle function in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 1998; 158: 734-741.
9. Culebras A. Sleep and neuromuscular disorders. Neurol Clin 2005; 23: 1209-1223.
10. Schneerson JM, Simonds AK. Noninvasive ventilation for chest wall and neuromuscular disorders. Eur Respir J 2002; 20: 480-487.
11. Ono S, Takahashi K, Kanda F, et al. Decrease of neurons in the medullary arcuate nucleus in myotonic dystrophy. Acta Neuropathol 2001; 102: 89-93.
12. Toussaint M, Steens M, Soudon P. Lung function accurately predicts hypercapnia in patients with Duchenne muscular dystrophy. Chest 2007; 131: 368-375.
13. Phillips MF, Quinlivan RCM, Edwards RHT, et al. Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med 2001; 164: 2191-2194.
14. American Thoracic Society, European Respiratory Society, ATS/ERS Statement on Respiratory Muscle Testing. Am J Respir Crit Care Med 2002; 166: 518-624.
15. Windisch W, Hennings E, Sorichter S, et al. Peak or plateau maximal inspiratory mouth pressure: which is best? Eur Respir J 2004; 23: 708-713.
16. Finder JD, Brinkrant D, Carl J, et al. Respiratory care of the patient with Duchenne muscular dystrophy. ATS Consensus Statement. Am J Respir Crit Care Med 2004; 170: 456-465.
17. Ciafaloni E, Moxley RT. Treatment options for Duchenne muscular dystrophy. Curr Treat Options Neurol 2008; 10: 86-93.
18. Mehta S. Neuromuscular disease causing acute respiratory failure. Respir Care 2006; 51: 1016-1021.
19. Lloyd-Owen SJ, Donaldson GC, Ambrosino N, et al. Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J 2005; 25: 1025-1031.
20. Toussaint M, Steens M, Wasteels, et al. Diurnal ventilation via mouthpiece: survival in end-stage Duchenne patients. Eur Respir J 2006; 28: 549-555.
21. Hess DR. Noninvasive ventilation in neuromuscular disease: equipment and application. Respir Care 2006; 51: 896-911.
22. Hart N, Hunt A, Polkey MI, et al. Comparison of proportional assist ventilation and pressure support ventilation in chronic respiratory failure due to neuromuscular and chest wall deformity. Thorax 2002; 57: 979-998.
23. Simonds AK. Recent advances in respiratory care for neuromuscular disease. Chest 2006; 130: 1879-1886.
24. Ozsancak A, D'Ambrosio C, Hill NS. Nocturnal noninvasive ventilation. Chest 2008; 133: 1275-1286.
25. Windisch W. Quality of life in home mechanical ventilation study group, Impact of home mechanical ventilation on health-related quality of life. Eur Respir J 2008; 32: 1328-1336.
26. Hill NS, Eveloff SE, Carlisle CC, et al. Efficacy of nocturnal nasal ventilation in patients with restrictive thoracic disease. Am Rev Respir Dis 1992; 145: 365-371.
27. Masa Jiménez JF, Sánchez de Cos Escuin J, Disdier Vicente C, et al. Nasal intermittent positive pressure ventilation: analysis of its withdrawal. Chest 1995; 107: 383-388.
28. Leger P, Bedicam JM, Cornette A, et al. Nasal intermittent positive pressure ventilation: long term follow-up in patients with severe chronic respiratory insufficiency. Chest 1994; 105: 100-105.
29. Simonds AK, Elliott MW. Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. Thorax 1995; 50: 604-609.
30. Simonds AK, Muntoni F, Heather S, et al. Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax 1998; 53: 949-952.
31. Kohler M, Clarenbach CF, Boni L, et al. Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med 2005; 172: 1032-1036.
32. Schönhofer B, Von Sydow K, Bucher T, et al. Sexuality in patients with noninvasive mechanical ventilation due to chronic respiratory failure. Am J Respir Crit Care Med 2001; 164: 1612-1617.
33. Simonds AK. Domiciliary non-invasive ventilation in restrictive disorders and stable neuromuscular disease. In: Simonds AK, ed. Non-invasive Respiratory Support: A Practical Handbook. London, Arnold, 2001; pp. 133-145.
34. Annane D, Orlikowski D, Chevret S, et al. Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders. Cochrane Database Syst Rev 2007; 4: CD001941.
35. Toussaint M, Soudon P, Kinnear W. Effect of non-invasive ventilation on respiratory muscle loading and endurance in patients with Duchenne muscular dystrophy. Thorax 2008; 63: 430-434.
36. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344: 1688-1700.
37. Laub M, Midgren B. Survival of patients on home mechanical ventilation: a nationwide prospective study. Respir Med 2007; 101: 1074-1078.
38. Aboussouan LS, Khan SU, Meeker DP, et al. Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997; 127: 450-453.
39. Bourke SC, Bullock RE, Williams TL, et al. Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology 2003; 61: 171-177.
40. Farrero E, Prats E, Povedano M, et al. Survival in amyotrophic lateral sclerosis with home mechanical ventilation: the impact of systematic respiratory assessment and bulbar involvement. Chest 2005; 127: 2132-2138.
41. Bourke SC, Tomlinson M, Williams TL, et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomized controlled trial. Lancet Neurol 2006; 5: 140-147.
42. Peysson S, Vandenberghe N, Philit F, et al. Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis. Eur Neurol 2008; 5: 164-171.
43. Lo Coco D, Marchese S, Pesco MC, et al. Noninvasive positive-pressure ventilation in ALS: predictors of tolerance and survival. Neurology 2006; 67: 761-765.
44. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation - a consensus conference report. Chest 1999; 116: 521-534.
45. Raphael JC, Chevret S, Chastang C, et al. Randomized trial of preventive nasal ventilation in Duchenne muscular dystrophy. Lancet 1994; 343: 1600-1604.
46. Ward S, Chatwin M, Heather S, et al. Randomized controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 2005; 60: 1019-1024.
47. Lechtzin N, Scott Y, Busse AM, et al. Early use of non-invasive ventilation prolongs survival in subjects with ALS. Amyotroph Lateral Scler 2007; 8: 185-188.
48. Dreher M, Rauter I, Storre JH, et al. When should home mechanical ventilation be started in patients with different neuromuscular disorders? Respirology 2007; 12: 749-753.
49. Bach JR. A comparison of long-term ventilatory support alternatives from the perspective of the patient and care giver. Chest 1993; 104: 1702-1706.
50. Bach JR, Intintola P, Alba AS, et al. The ventilator-assisted individual: cost analysis of institutionalization versus rehabilitation and in-home management. Chest 1992; 101: 26-30.
51. Lofaso F, Orlikowski D, Raphael JC. Ventilatory assistance in patients with Duchenne muscular dystrophy. Eur Respir J 2006; 28: 468-469.
52. Bach JR. A comparison of long-term ventilatory support alternatives from the perspective of the patient and care giver. Chest 1993; 104: 1702-1706.
53. Bach JR, Intintola P, Alba AS, et al. The ventilator individual: cost analysis of institutionalization versus rehabilitation and in-home management. Chest 1992; 101: 26-30.
54. Marchese S, Lo Coco D, Lo Coco A. Outcome and attitudes toward home tracheostomy ventilation of consecutive patients: a 10-year experience. Respir Med 2008; 102: 430-436.
55. Vitacca M, Callegari G, Sarva M, et al. Physiological effects of meals in difficult-to-wean tracheostomised patients with chronic obstructive pulmonary disease. Intensive Care Med 2005; 31: 236-242.
56. Terzi N, Orlikowski D, Aegerter P, et al. Breathing-swallowing interaction in neuromuscular patients. A physiological evaluation. Am J Respir Crit Care Med 2007; 175: 269-276.
57. Andersen PM, Borasio GD, Dengler R, et al. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler 2007; 8: 195-213.
58. Bach JR. Respiratory muscle aids: patient evaluation, respiratory aid protocol, and outcomes. In: Bach JR, ed. The Management of Patients with Neuromuscular Disease. Philadelphia, Hanley and Belfus, 2004: pp. 271-308.
59. Bach JR, Sabharwal S. High pulmonary risk scoliosis surgery: role of noninvasive ventilation and related techniques. J Spinal Disord Tech 2005; 18: 527-530.
60. Pryor JA. Physiotherapy for airway clearance in adults. Eur Respir J 1999; 14: 1418-1424.
61. Gosselink R. Respiratory physiotherapy. In: Donner CF, Ambrosino N, Goldstein RS, eds. Pulmonary Rehabilitation. London, Hodder Arnold, 2005; pp. 186-194.
62. Kang SW, Bach JR. Maximum insufflation capacity: the relationships with vital capacity and cough flows for patients with neuromuscular disease. Am J Phys Med Rehabil 2000; 79: 222-227.
63. Miske LJ, Hickey EM, Kolb SM, et al. Use of the mechanical inexsufflator in pediatric patients with neuromuscular disease and impaired cough. Chest 2004; 125: 1406-1412.
64. Fauroux B, Guillemot N, Aubertin G, et al. Physiologic benefits of mechanical insufflation-exsufflation in children with neuromuscular diseases. Chest 2008; 133: 161-168.
65. Winck JC, Gonçalves MR, Lourenço C, et al. Effects of mechanical insufflation-exsufflation on respiratory parameters for patients with chronic airway secretion encumbrance. Chest 2004; 126: 774-780.
66. Chatwin M, Ross E, Hart N, et al. Cough augmentation with mechanical insufflation/exsufflation inpatients with neuromuscular weakness. Eur Respir J 2003; 21: 502-508.
67. Vianello A, Corrado A, Arcaro G, et al. Mechanical insufflation-exsufflation improves outcomes for neuromuscular disease patients with respiratory tract infections. Am J Phys Med Rehabil 2005; 84: 83-88.
68. Suri P, Burns SP, Bach JR. Pneumothorax associated with mechanical insufflation-exsufflation and related factors. Am J Phys Med Rehabil 2008; 87: 951-955.
69. Vianello A, Bevilacqua M, Arcaro G. Noninvasive ventilatory approach to treatment of acute respiratory failure in neuromuscular disorders: a comparison with endotracheal intubation. Intensive Care Med 2000; 26: 384-390.
70. Servera E, Sancho J, Zafra MJ, et al. Alternatives to endotracheal intubation for patients with neuromuscular diseases. Am J Phys Med Rehabil 2005; 84: 851-857.
71. Rabinstein A, Widjicks EF. BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation. Neurology 2002; 59: 1647-1649.
72. Bach JR, Ishikawa Y, Kim H. Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest 1997; 112: 1024-1028.
73. Curtis JR. Palliative and end-of-life care for patients with severe COPD. Eur Respir J 2008; 32: 796-803.
74. Clinical Practice Guidelines for Quality Palliative Care. National Consensus Project for Quality Palliative Care. www.nationalconsensusproject.org/ guideline.pdf Date last accessed: June 17, 2007.
75. Shanawani H, Wenrich MD, Tonelli MR, et al. Meeting physicians' responsibilities in providing end-of-life care. Chest 2008; 133: 775-778.
76. Murray SA, Kendall M, Boyd K, et al. Illness trajectories and palliative care. BMJ 2005; 330: 1007-1011.
77. Lunney JR, Lynn J, Foley DJ, et al. Patterns of functional decline at the end of life. JAMA 2003; 289: 2387-2392.
78. Nava S, Sturani C, Hartl S, et al. End-of-life decision-making in respiratory intermediate care units: a European survey. Eur Respir J 2007; 30: 156-164.
79. Qaseem A, Snow V, Shekelle P, et al. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2008; 148: 141-146.
80. Truog RD, Campbell ML, Curtis JR, et al. Recommendations for end-of-life care in the intensive care unit: a consensus statement by the American College of Critical Care Medicine. Crit Care Med 2008; 36: 953-963.
81. Lorenz KA, Lynn J, Dy SM, et al. Evidence for improving palliative care at the end of life: a systematic review. Ann Intern Med 2008; 148: 147-159.
82. Ambrosino N, Simonds A. The clinical management in extremely severe COPD. Respir Med 2007; 101: 1613-1624.
83. Clini EM, Ambrosino N. Nonpharmacological treatment and relief of symptoms in COPD. Eur Respir J 2008; 32: 218-228.
84. Curtis JR, Cook DJ, Sinuff T, et al. Noninvasive positive pressure ventilation in critical and palliative care settings: Understanding the goals of therapy. Crit Care Med 2007; 35: 932-939.